SRF
SRF · NSE · Large Cap
SRF
Specialty chemicals and films; secondary solar exposure via fluoropolymers and films.
Scoring breakdown
SageOne-style fundamental · TQ-100 technical · solar overlays
52-week position
Real snapshot from Screener
Investment thesis
One-liner · bull · bear · monitorables
One-liner. SRF: ancillary solar input exposure via fluoropolymers / soda ash / silver pastes.
Bull case for SRF: continued capacity ramp at attractive unit economics, supportive policy (PLI / ALMM / RPO / open access), benign module + commodity cycle, healthy receivable conversion, and re-rating from current valuation as execution beats consensus.
Bear case for SRF: module/tariff price crash, working-capital blowout from DISCOM receivables, leverage spiking past 4x net-debt/EBITDA, ALMM/PLI delays, Chinese dumping, and de-rating to historical median multiples on growth disappointment.
- 01Quarterly capacity commissioned vs guidance
- 02Receivable days from DISCOMs and large customers
- 03Net debt / EBITDA trajectory
- 04Order book to revenue cover
Solar exposure
Directness · policy linkage · BOM
Valuation snapshot
Multiple methods · solar-specific multiples
| Method | Value | Hist %ile |
|---|---|---|
| P/E (TTM) | 43.6x | — |
| Forward P/E | — | — |
| EV/EBITDA | 25.8x | — |
| EV/Sales | 5.6x | — |
| P/B | 5.9x | — |
| FCF Yield | 1.2% | — |
Project pipeline
0 tracked projects
Financials
Source: Screener.in (consolidated) · ticker SRF · last updated 2026-05-11
Ratio analysis (derived from statements)
Growth · profitability · returns · leverage · cash flow · valuation
Annual P&L · 5 years
₹ Crore. Source: Screener.in consolidated.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 12,434 | 14,870 | 13,139 | 14,693 | 15,787 |
| Operating Profit | 3,103 | 3,529 | 2,584 | 2,718 | 3,410 |
| OPM % | 25% | 24% | 20% | 18% | 22% |
| Net Profit | 1,889 | 2,162 | 1,336 | 1,251 | 1,835 |
| EPS (₹) | 63.72 | 72.95 | 45.06 | 42.20 | 61.91 |
Quarterly results · last 4 quarters
₹ Crore.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|
| Sales | 3,491 | 4,313 | 3,819 | 3,640 |
| OPM % | 18% | 22% | 22% | 21% |
| Net Profit | 271 | 526 | 432 | 388 |
Balance sheet · 5 years
₹ Crore.
| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 297 | 297 | 297 | 297 | 297 |
| Reserves | 8,268 | 10,030 | 11,182 | 12,329 | 13,745 |
| Borrowings | 3,655 | 4,478 | 5,031 | 4,726 | 5,083 |
| Fixed Assets | — | — | — | — | — |
| Total Assets | 15,765 | 18,736 | 20,454 | 21,521 | 24,147 |
Cash flow · 5 years
₹ Crore.
| Activity | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 2,106 | 2,902 | 2,094 | 2,487 | 2,554 |
| Investing | -1,586 | -2,964 | -2,231 | -1,482 | -1,598 |
| Financing | -207 | 220 | -72 | -1,071 | -708 |
| Net Cash Flow | 313 | 158 | -209 | -66 | 248 |
Shareholding pattern
Latest disclosed
Policy linkages
Schemes where this company is a confirmed or likely beneficiary